Karachi: IBL HealthCare Limited has released its financial results for the quarter ending September 30, 2026, revealing a minor move in revenue and several notable changes in other financial metrics. The report, dated October 29, 2026, highlights the company's performance amidst varying operational costs and tax expenses.
IBL HealthCare Limited recorded revenue from contracts with customers amounting to Rs. 1.12 billion, a marginal increase compared to Rs. 1.12 billion reported during the same period last year. Despite this increase in revenue, the company's gross profit saw a decline, coming in at Rs. 391.85 million, down from Rs. 400.09 million, indicating a need to manage rising costs of sales which reached Rs. 729.34 million compared to the previous Rs. 720.83 million.
The company's profit from operations was reported at Rs. 92.65 million, down from Rs. 132.32 million last year, primarily due to increased marketing and distribution expenses amounting to Rs. 238.64 million and administrative and general expenses rising to Rs. 68.17 million from Rs. 39.82 million. This increase in operational costs has put pressure on the company's profit margins.
According to information available from the Pakistan Stock Exchange (PSX), the finance cost for IBL HealthCare Limited saw a significant reduction to Rs. 1 million from Rs. 9.19 million, contributing positively to the company's financial standing. However, the profit before levies and income tax decreased to Rs. 91.65 million from Rs. 123.13 million.
The company's levies and minimum tax were recorded at Rs. 1.10 million, a substantial drop from Rs. 8.50 million in the previous year. After accounting for an income tax expense of Rs. 26.50 million, down from Rs. 44.94 million, the profit after taxation stood at Rs. 64.05 million, compared to Rs. 69.69 million last year.
Earnings per share for the period were reported at Rs. 0.65, slightly lower than the Rs. 0.71 recorded in the prior year. The total comprehensive income mirrored the profit after taxation, with no additional comprehensive income reported.
The quarterly results underscore a period of financial adjustments for IBL HealthCare Limited as they navigate fluctuating costs and tax obligations within the designated market category.